RARosanna Adone

Rosanna Adone

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rosanna Adone has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Antigenic, Immunologic and Genetic Characterization of Rough Strains B.abortus RB51, B.melitensis B115 and B.melitensis B18

    by Rosanna Adone, Michele Muscillo, Giuseppina La Rosa, Massimiliano Francia, Michela Tarantino

    The lipopolysaccharide (LPS) is considered the major virulent factor in Brucella spp. Several genes have been identified involved in the synthesis of the three LPS components: lipid A, core and O-PS. Usually, Brucella strains devoid of O-PS (rough mutants) are less virulent than the wild type and do not induce undesirable interfering antibodies. Such of them proved to be protective against brucellosis in mice. Because of these favorable features, rough strains have been considered potential brucellosis vaccines. In this study, we evaluated the antigenic, immunologic and genetic characteristics of rough strains B.abortus RB51, B.melitensis B115 and B.melitensis B18. RB51 derived from B.abortus 2308 virulent strain and B115 is a natural rough strain in which the O-PS is present in the cytoplasm. B18 is a rough rifampin-resistan mutant isolated in our laboratory. The surface antigenicity of RB51, B115 and B18 was evaluated by testing their ability to bind antibodies induced by rough or smooth Brucella strains. The antibody response induced by each strain was evaluated in rabbits. Twenty-one genes, involved in the LPS-synthesis, were sequenced and compared with the B.melitensis 16M strain. The results indicated that RB51, B115 and B18 have differences in antigenicity, immunologic and genetic properties. Particularly, in B115 a nonsense mutation was detected in wzm gene, which could explain the intracellular localization of O-PS in this strain. Complementation studies to evaluate the precise role of each mutation in affecting Brucella morphology and its virulence, could provide useful information for the assessment of new, attenuated vaccines for brucellosis.


  • B. melitensis rough strain B115 is protective against heterologous Brucella spp. infections

    by Rosanna Adone, Massimiliano Francia, Claudia Pistoia, Michele Pesciaroli, Paolo Pasquali


    • 1 January 2010
      • Vol. 33  (1) , 83-6

    Severe anthrax outbreaks in Italy in 2004: considerations on factors involved in the spread of infection.

    by Antonio Fasanella, Giuliano Garofolo, Domenico Galante, Vincenzo Quaranta, Lucia Palazzo, Florigo Lista, Rosanna Adone, Martin Hugh Jones

    Anthrax is a disease of humans and animals caused by the encapsulated, spore-forming Bacillus anthracis. In Italy, anthrax is normally a sporadic disease. During the summer 2004, anthrax broke out in the Basilicata, in southern Italy, a region with a low prevalence of anthrax in which vaccination had been suspended since 1998. The disease involved several animals in few weeks and in a large area. Over 41 days, 81 cattle died, as well as 15 sheep, 9 goats, 11 horses and 8 deer. The Multiple-locus Variable-Number Tandem Repeats Analysis (MLVA) showed that all the 53 isolates belonged to the Cluster Ala, genotype 1. The results of the Single Nucleotide Repeats (SNRs) Analysis showed that 48/53 B. anthacis strains belonged to a single clonal lineage, the sub-genotype sgt - eB. Two sporadic mutants, sgt - eB,m1 and sgt - eB,m2, were isolated, only one managing to infect other herds. Factors that could have contributed to the spread of infection, such as the transmission of spores by insect vectors and the favourable weather conditions were evaluated.


  • Brucella melitensisB115-based complement fixation test to detect antibodies induced byBrucellarough strains

    by R. Adone, M. Francia, F. Ciuchini

    Aims: To assess the efficiency of a Brucella melitensis B115 rough strain, naturally devoid of anticomplementary activity, used as antigen in a complement fixation test (CFT) to detect antibodies induced by Brucella strains with rough phenotype, such as Brucella abortus RB51, Brucella ovis and Brucella canis. Methods and Results: Complement fixation testing was performed on sera from RB51‐vaccinated cattle and buffaloes, B. ovis‐infected sheep and B. canis‐infected dogs using B115, RB51 and the hot saline extract (HSE) as antigens. The B115‐based CFT proved highly sensitive and specific in detecting rough antibodies and its efficiency was comparable with that of RB51 and HSE‐based CFT. Conclusions: Brucella melitensis B115 can be successfully used as an antigen in CFT to detect antibodies induced by Brucella rough strains. Significance and Impact of the Study: Brucella melitensis B115 antigen may represent an improvement over Brucella rough strains for Brucella antibody detection by CFT, thus enhancing the efficiency of brucellosis surveillance systems. Owing to the absence of anticomplementary activity, it does not require particular growth conditions or modifications and can be accurately standardized. The B115‐based CFT may constitute a suitable supplementary test for the diagnosis of human infections owing to rough Brucellae.


    • 1 October 2006
      • Vol. 29  (4) , 307-10

    Molecular study of genes involved in virulence regulatory pathways in Bacillus anthracis vaccine strain "Carbosap".

    by Giuseppina La Rosa, Michele Muscillo, Michela Sali, Elena De Carolis, Cinzia Marianelli, Franco Ciuchini, Antonio Fasanella, Rosanna Adone

    This study investigated the genetic bases of attenuation in the Bacillus anthracis vaccine strain "Carbosap" used in Italy against anthrax in cattle and sheep. Twelve genes involved in virulence regulatory pathways underwent sequence analysis in comparison with a B. anthracis virulent strain.


  • Open Access

    Protective Properties of Rifampin-Resistant Rough Mutants ofBrucella melitensis

    by R. Adone, F. Ciuchini, C. Marianelli, M. Tarantino, C. Pistoia, G. Marcon, P. Petrucci, M. Francia, G. Riccardi, P. Pasquali

    Vaccination againstBrucellainfections in animals is usually performed by administration of live attenuated smoothB. abortusstrain S19 andB. melitensisstrain Rev1. They are proven effective vaccines againstB. abortusin cattle and againstB. melitensisandB. ovisin sheep and goats, respectively. However, both vaccines have the main drawback of inducing O-polysaccharide-specific antibodies that interfere with serologic diagnosis of disease. In addition, they retain residual virulence, being a cause of abortion in pregnant animals and infection in humans. To overcome these problems, one approach is to develop defined rough mutantBrucellastrains lacking O antigen of lipopolysaccharide.B. abortusrough strain RB51, a rifampin-resistant mutant of virulent strainB. abortus2308, is used as a vaccine againstB. abortusinfection in cattle in some countries. However, RB51 is not effective in sheep, and there is only preliminary evidence that it is effective in goats. In this study, we tested the efficacies of six rifampin-resistant rough strains ofB. melitensisin protecting BALB/c mice exposed toB. melitensisinfection. The protective properties, as well as both humoral and cellular immune responses, were assessed in comparison with those provided byB. melitensisRev1 andB. abortusRB51 vaccines. The results indicated that these rough mutants were able to induce a very good level of protection againstB. melitensisinfection, similar to that provided by Rev1 and superior to that of RB51, without inducing antibodies to O antigen. In addition, allB. melitensismutants were able to stimulate good production of gamma interferon. The characteristics of these strains encourage further evaluation of them as alternative vaccines to Rev1 in primary host species.


  • Open Access

    Combined S99/RB51 antigen for complement fixation test for serological diagnosis of brucellosis in cattle and sheep

    by R. Adone, F. Ciuchini, C. Pistoia, P. Pasquali

    Aims: To assess the efficiency of a single antigen for the complement fixation (CF) test, prepared by combining Brucella abortus smooth strain 99 (S99) with Brucella abortus rough strain RB51(RB51),...


  • Open Access

    Sequence analysis of the genes encoding for the major virulence factors ofBacillus anthracisvaccine strain `Carbosap'

    by R. Adone, P. Pasquali, G. La Rosa, C. Marianelli, M. Muscillo, A. Fasanella, M. Francia, F. Ciuchini

    Aims: This study was performed to analyse the molecular characteristics of genes encoding for the major virulence factors in Bacillus anthracis vaccine strain `Carbosap' compared with the wild B. an...


  • Open Access

    Field Validation of the Use of RB51 as Antigen in a Complement Fixation Test To Identify Calves Vaccinated withBrucella abortusRB51

    by Rosanna Adone, Franco Ciuchini, Steven Olsen

    In order to confirm the efficiency of an experimental RB51-based complement fixation (CF) test in identifying cattle vaccinated withBrucella abortusstrain RB51, 831 sera from 110 vaccinated and 48 unvaccinated Hereford heifers of Iowa, collected for studies conducted in different years, were sent to Italy without coding to be tested in a CF test using RB51 as antigen. Most of the calves, aged from 3 to 10 months, were vaccinated subcutaneously with the recommended dosage of 1010CFU of RB51 commercial vaccine, while only six calves received 109CFU of the same vaccine. Serum samples for serologic testing, collected until 16 postinoculation weeks (PIW), were also tested by routine surveillance tests for brucellosis such as rose bengal plate and CF tests performed withB. abortussmooth strain 99 as control antigen. RB51 CF test results obtained by testing sera from cattle vaccinated in 1999 indicate that the sensitivity of the reaction is 97% at 2 to 3 PIW and 90% until 8 PIW and decreases to 65% at 12 PIW, the specificity remaining at 100%. Collectively, the results of this study confirm that serologic standard tests fail to detect antibodies to RB51 while the RB51-based CF test is able to monitor antibody responses to RB51 until 15 to 16 PIW with a specificity of 100%. In addition, unlike the RB51-based dot blot assay, which is the only test currently used to monitor antibody responses to RB51, the CF test also detected specific responses following vaccination with 109CFU of RB51, although seroconversion was only 50% at 8 PIW. In conclusion, because of high specificity and sensitivity, the CF test described here can be used to efficaciously monitor serologic responses following RB51 vaccination in cattle and could also be employed to detect RB51 infection in humans exposed to this strain.